Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: PncA sequencing versus Bactec MGIT 960

Tuberculosis

Volumn 95, Issue 5, 2015, Pages 608-612

  Maslov, Dmitry A ^a   Zaîchikova, Marina V ^a   Chernousova, Larisa N ^b   Shur, Kirill V ^a   Bekker, Olga B ^a   Smirnova, Tatiana G ^b   Larionova, Elena E ^b   Andreevskaya, Sofya N ^b   Zhang, Ying ^c   Danilenko, Valery N ^a  

^a VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Drug susceptibility testing; MGIT960; pncA; Pyrazinamide; Resistance; Tuberculosis

Indexed keywords

BACTERIAL DNA; PYRAZINAMIDE; AMIDASE; PNCA PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PAND GENE; PNCA GENE; PRIORITY JOURNAL; RPSA GENE; RUSSIAN FEDERATION; SEQUENCE ANALYSIS; COMPARATIVE STUDY; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION; PATHOGENICITY; PHENOTYPE; PREDICTIVE VALUE; PREVALENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

AMIDOHYDROLASES; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PYRAZINAMIDE; RUSSIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84940460611     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.05.013     Document Type: Article

References (26)

1. World Health Organization Global tuberculosis report 2014 2014 WHO Geneva, Switzerland
2. D.A. Mitchison The action of antituberculosis drugs in short-course chemotherapy Tubercle 66 1985 219 225
3. World Health Organization Treatment of tuberculosis 2010 WHO Geneva, Switzerland
4. Y. Zhang, and D. Mitchison The curious characteristics of pyrazinamide: a review Int J Tuberc Lung Dis 7 2003 6 21
5. A. Scorpio, and Y. Zhang Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus Nat Med 2 1996 662 667
6. A. Scorpio, P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis Antimicrob Agents Chemother 41 1997 540 543
7. S.J. Cheng, L. Thibert, T. Sanchez, L. Heifets, and Y. Zhang pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada Antimicrob Agents Chemother 44 2000 528 532
8. W. Shi, X. Zhang, X. Jiang, H. Yuan, J.S. Lee, C.E. Barry, and et al. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis Science 333 2011 1630 1632 10.1126/science.1208813
9. S.O. Simons, A. Mulder, J. van Ingen, M.J. Boeree, and D. van Soolingen Role of rpsA gene sequencing in diagnosis of pyrazinamide resistance J Clin Microbiol 51 2013 382 10.1128/JCM.02739-12
10. M. Thibonnier, J.-M. Thiberge, and H. De Reuse Trans-translation in Helicobacter pylori: essentiality of ribosome rescue and requirement of protein tagging for stress resistance and competence PLoS One 3 2008 e3810 10.1371/journal.pone.0003810
11. A. Muto, A. Fujihara, K.I. Ito, J. Matsuno, C. Ushida, and H. Himeno Requirement of transfer-messenger RNA for the growth of Bacillus subtilis under stresses Genes Cells 5 2000 627 635
12. S. Zhang, J. Chen, W. Shi, W. Liu, W. Zhang, and Y. Zhang Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis Emerg Microbes Infect 2 2013 e34 10.1038/emi.2013.38
13. C. Piersimoni, A. Olivieri, L. Benacchio, and C. Scarparo Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems J Clin Microbiol 44 2006 20 28 10.1128/JCM.44.1.20-28.2006
14. P. Chedore, L. Bertucci, J. Wolfe, M. Sharma, and F. Jamieson Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide J Clin Microbiol 48 2010 300 301 10.1128/JCM.01775-09
15. S.O. Simons, J. van Ingen, T. van der Laan, A. Mulder, P.N.R. Dekhuijzen, M.J. Boeree, and et al. Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide J Clin Microbiol 50 2012 428 434 10.1128/JCM.05435-11
16. Y. Zhang, K. Chiu Chang, C.-C. Leung, W. Wai Yew, B. Gicquel, D. Fallows, and et al. 'ZS-MDR-TB' versus 'ZR-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility Emerg Microbes Infect 1 2012 e5 10.1038/emi.2012.18
17. A.A. Prozorov, M.V. Zaichikova, and V.N. Danilenko Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges Russ J Genet 48 2012 1 14 10.1134/S1022795411120118
18. S. Zhdanova, S.K. Heysell, O. Ogarkov, G. Boyarinova, G. Alexeeva, S. Pholwat, and et al. Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation Emerg Infect Dis 19 2013 1649 1652 10.3201/eid1910.121108
19. N. Casali, V. Nikolayevskyy, Y. Balabanova, S.R. Harris, O. Ignatyeva, I. Kontsevaya, and et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population Nat Genet 46 2014 279 286 10.1038/ng.2878
20. S.H. Siddiqi Guidelines for second-line drug susceptibility testing in MGIT based on published studies Crit Concentrations Proced 2014 1 26
21. L.G.L. Wayne Simple pyrazinamidase and urease tests for routine identification of mycobacteria Am Rev Respir Dis 109 1973 147 151
22. J. Ye, G. Coulouris, I. Zaretskaya, I. Cutcutache, S. Rozen, and T.L. Madden Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction BMC Bioinformatics 13 2012 134 10.1186/1471-2105-13-134
23. W. Shi, J. Chen, J. Feng, P. Cui, S. Zhang, X. Weng, and et al. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis Emerg Microbes Infect 3 2014 e58 10.1038/emi.2014.61
24. S. Sreevatsan, X. Pan, Y. Zhang, B.N. Kreiswirth, and J.M. Musser Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms Antimicrob Agents Chemother 41 1997 636 640
25. D.A. Maslov, K.V. Shur, O.B. Bekker, N.V. Zakharevich, M.V. Zaîchikova, K.M. Klimina, and et al. Draft genome sequence of two pyrazinamide-resistant clinical isolates of Mycobacterium tuberculosis 13-4152 and 13-2459 Genome Announc 2015 [Forthcoming]
26. Y. Zhang, W.W. Yew, and M.R. Barer Targeting persisters for tuberculosis control Antimicrob Agents Chemother 56 2012 2223 2230 10.1128/AAC.06288-11